Benzodiazepines and sedative-hypnotics in blood of drivers under the influence and their association with other common illegal drug use and national sales figures

Therapeutic Drug Monitoring

Volumn 33, Issue 1, 2011, Pages 64-71

  Blencowe, Tom ^a   Raaska, Kari ^b   Lillsunde, Pirjo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Kellokoski Hospital   (Finland)

Author keywords

amphetamines; benzodiazepines and sedative hypnotics; cannabis; driving under the influence; drug measurements; zero tolerance law

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; CLONAZEPAM; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; LORAZEPAM; NORDAZEPAM; OXAZEPAM; TEMAZEPAM; ZOLPIDEM; ZOPICLONE;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CAR DRIVING; DATA BASE; DEVICE; DRIVER UNDER THE INFLUENCE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MARKETING; DRUG METABOLISM; DRUG STRUCTURE; DRUG USE; FINLAND; HUMAN; LAW; MAJOR CLINICAL STUDY; MISCELLANEOUS NAMED GROUPS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCREENING;

AMPHETAMINES; AUTOMOBILE DRIVING; BENZODIAZEPINES; DRUG USERS; FINLAND; HUMANS; HYPNOTICS AND SEDATIVES; MARIJUANA ABUSE; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 78751641449     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182030f91     Document Type: Article

References (43)

1. Ashton CH. Benzodiazepines: how they work and how to withdraw [The Ashton Manual web site]. August 2002. Available at: www.benzo.org.uk/manual/index.htm. Accessed June 22, 2010.
2. Ashton CH. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18:249-255.
3. Drummer OH. The Forensic Pharmacology of Drugs of Abuse. London: Arnold; 2001.
4. Drover D. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives zalepon, zopidem and zopiclone. Clin Pharmacokinet. 2004;43:227-238.
5. Bramness JG, Skurtveit S, Morland J. Clinical impairment of benzodiazepines-relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend. 2002;68: 131-141.
6. Morland J. Driving under the influence of non-alcohol drugs. Forensic Sci Rev. 2000;12:80-105.
7. Verster J, Volkerts E, Schreuder A, et al. Residual effects of middle-of-thenight administration of Zalepon and Zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol. 2002; 22:576-583.
8. Gustavsen I, Al-Sammurraie M, Morland J, et al. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev. 2009;41:462-466.
9. Orriols L, Salmi L, Philip P, et al. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf. 2009;18:647-658.
10. De Gier JJ. Review of investigations of prevalence of illicit drugs in road traffic in different European countries. In: Road Traffic and Drugs: Seminar by Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group). Strasbourg, Germany: Council of Europe Publishing; 1999:13-61.
11. Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004;23: 319-344. (Pubitemid 39305501)
12. Lillsunde P. Drugs and Driving-Analytical and epidemiological aspects [dissertation]. Helsinki: Kansanterveylaitos; 1996.
13. Ashton CH. Benzodiazepine Abuse [Professor C Heather Ashton website]. 2002. Available at: www.benzo.org.uk/ashbzab.htm. Accessed May 25, 2010.
14. Lillsunde P, Korte T, Michelson L, et al. Drugs usage of drivers suspected of driving under the influence of alcohol and/or drugs. A study of one week's samples in 1979 and 1993 in Finland. Forensic Sci Int. 1996;77: 119-129.
15. Christophersen AS, Ceder G, Kristinsson J, et al. Drugged driving in the Nordic countries - a comparative study between five countries. Forensic Sci Int. 1999;106:173-190.
16. Lillsunde P. Commentary: alcohol/drug users and traffic accidents - a review on epidemiological studies. J Traffic Med. 1998;26:5-10.
17. Ojaniemi KK, Lintonen TR, Impinen AO, et al. Trends in driving under the influence of drugs: a register-based study on DUID suspects during 1977-2007. Accid Anal Prev. 2009;41:191-196.
18. Gerostamoulos J, McCaffrey P, Drummer OH, et al. Drug profiles of apprehended drivers in Victoria. In: Mayhew DR, Dussault C, eds. Alcohol, Drugs and Traffic Safety-T 2002.
19. Proceedings of the 16th International Conference on Alcohol, Drugs and Traffic Safety, Montreal, August 4-9, 2002. Montreal: Société de l'assurance automobile du Québec; 2002:441-5. Available at: www.saaq.gouv.qc.ca/t2002/actes/pdf/(17a).pdf. Accessed June 22, 2010.
20. Walsh MJ, Flegel R, Atkins R, et al. Drug and alcohol use among drivers admitted to a Level-1 trauma center. Accid Anal Prev. 2005;37: 894-901.
21. Drummer OH, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int. 2003; 134:154-162.
22. Ch'ng CW, Fitzgerald M, Gerostamoulos J, et al. Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre. Emerg Med Australas. 2007;19:359-365.
23. Holmgren A, Holmgren P, Kugelberg F, et al. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden. Traffic Inj Prev. 2007;8:361-367.
24. Lillsunde P, Gunnar T. Drugs and driving; the Finnish perspective. Bull Narc. 2005;LVII:213-219.
25. Jones AW, Holmgren A, Kugelberg FC. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther Drug Monit. 2007;29:248-260.
26. Skurtveit S, Christophersen AS, Morland J. Driving under the influence of benzodiazepines. Tidsskr Nor Laegeforen. 1995;115:200-203.
27. Lillsunde P, Seppälä T. Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel gas chromatography using electron capture and nitrogen-phosphorus detection. J Chromatogr B Analyt Technol Biomed Life Sci. 1990;533:97-110.
28. Lillsunde P, Korte T. Determination of ring-substituted and N-substituted amphetamines as heptafluorobutyryl derivatives. Forensic Sci Int. 1991; 49:205-213.
29. Lillsunde P, Korte T, Michelson L, et al. Drugs usage of drivers suspected of driving under the influence of alcohol and/or drugs. A study of one week's samples in 1979 and 1993 in Finland. Forensic Sci Int. 1996;77: 119-129.
30. Gunnar T, Engblom C, Ariniemi K. Pressure-adjusted continual flow heart-cutting for the high throughput determination of amphetamine-type stimulant drugs in whole blood by fast multidimensional gas chromatography-mass spectrometry. J Chromatogr A. 2007;1166: 171-180.
31. Gunnar T, Mykkanen S, Ariniemi K, et al. Validated semiquantitative/ quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;806:205-219.
32. Kankaanpaa A, Gunnar T, Ariniemi K, et al. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;810:57-68.
33. Pehrsson A, Gunnar T, Engblom C, et al. Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008;175:140-148.
34. Rajala P, Ariniemi K, Mykkanen S, et al. Screening for abused drugs in blood samples using modified EMIT immunoassay. 6th Conference of the International Society of Addiction Medicine, Helsinki, June 2-5, 2004.
35. DDD-Definitions and general principles [WHO Collaborating Centre for Drug Statistics Methodology web site]; December 17, 2009. Available at: www.whocc.no/ddd/definition-and-general-considera/. Accessed October 30, 2010.
36. Jones AW, Holmgren A, Holmgren P. High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present. Forensic Sci Int. 2004;146: 1-7.
37. Christophersen AS, Morland J. Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev. 2008;9:98-104.
38. Jones AW, Holmgren A. Abnormally high concentrations of amphetamine in blood of impaired drivers. J Forensic Sci. 2005;50:1215-1220.
39. Poliisi on tyytyväinen huumetestereihin [Finnish Ministry of the Interior web site]. October 4, 2005. Available at: www.intermin.fi/intermin/ bulletin.nsf/vwSearchView/934080EE02041085C22570900041D8D6. Accessed June 22, 2010.
40. Verstraete AG, Raes E, eds. Rosita-2 Project Final Report. Gent: Academia Press; 2006.
41. Blencowe T, Pehrsson A, Lillsunde P, eds. Analytical evaluation of oral fluid screening devices and preceding selection procedures. DRUID report; 2010. Available at www.druid-project.eu. Accessed May 25, 2010.
42. Pehrsson A, Blencowe T, Vimpari K, et al. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device. Int J Legal Med. July 23, 2010 [epub ahead of print].
43. Wille SMR, Samyn N, Ramirez-Fernandez MDM, et al. Evaluation of on-site oral fluid screening using Drugwipe-5(+)(R), RapidSTAT (R) and Drug Test 5000 (R) for the detection of drugs of abuse in drivers. Forensic Sci Int. 2009;198:2-6.